Clinical Trial Update: Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Mesenchymal stromal cells in infants with congenital heart disease (MedCaP); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Mesenchymal stromal cells (MedCaP) (mesenchymal stromal cells)

Snippet

Sponsor: Catherine Bollard | Conditions: Congenital Heart Disease (CHD) | Phase 1 | Status: ACTIVE_NOT_RECRUITING